PMC:7228307 / 40050-40101 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7228307","sourcedb":"PMC","sourceid":"7228307","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7228307","text":"Fc engineering for enhanced anticancer therapeutics","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T716","span":{"begin":0,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"attributes":[{"subj":"T716","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sample-sentences","denotations":[{"id":"T225","span":{"begin":0,"end":51},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T225","pred":"source","obj":"LitCovid-sample-sentences"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T225","span":{"begin":0,"end":51},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T225","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#e793ec","default":true},{"id":"LitCovid-sample-sentences","color":"#93eccd"},{"id":"LitCovid-sentences","color":"#ecb393"}]}]}}